K. Fitzgerald

发表

Sensing intracellular oxygen using near-infrared phosphorescent probes and live-cell fluorescence imaging.

Dmitri B Papkovsky, C. Taylor, J. Hynes, 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex

E. Reinherz, S. Meuer, S. Schlossman, 1982, Cell.

Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker.

T. Kaneko, G. Spitalny, K. Fitzgerald, 1990, Cancer research.

An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein

E. Reinherz, S. Meuer, O. Acuto, 1984, Cell.

Identification of the receptor for antigen and major histocompatibility complex on human inducer T lymphocytes.

E. Reinherz, S. Meuer, S. Schlossman, 1983, Science.

Activation of human thymocytes via the 50KD T11 sheep erythrocyte binding protein induces the expression of interleukin 2 receptors on both T3+ and T3- populations.

E. Reinherz, J. Daley, D. Fox, 1985, Journal of immunology.

Comparison of T3-associated 49- and 43-kilodalton cell surface molecules on individual human T-cell clones: evidence for peptide variability in T-cell receptor structures.

E. Reinherz, S. Meuer, O. Acuto, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody.

E. Reinherz, J. Daley, O. Acuto, 1984, Journal of Immunology.

Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex

E. Reinherz, S. Meuer, S. Schlossman, 1983, The Journal of experimental medicine.

Cellular origin of interleukin 2 (IL 2) in man: evidence for stimulus-restricted IL 2 production by T4+ and T8+ T lymphocytes.

B. Stadler, E. Reinherz, S. Meuer, 1982, Journal of immunology.

Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations.

E. Reinherz, C. Morimoto, J. Daley, 1982, Journal of immunology.

Human cytotoxic T cell clones directed at autologous virus-transformed targets: further evidence for linkage of genetic restriction to T4 and T8 surface glycoproteins.

E. Reinherz, S. Meuer, S. Schlossman, 1983, Journal of immunology.

The human T cell receptor: Appearance in ontogeny and biochemical relationship of α and β subunits on IL-2 dependent clones and T cell tumors

E. Reinherz, S. Meuer, O. Acuto, 1983, Cell.

Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency.

E. Reinherz, R. Geha, F. Rosen, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Formulation and Evaluation of Anisamide-Targeted Amphiphilic Cyclodextrin Nanoparticles To Promote Therapeutic Gene Silencing in a 3D Prostate Cancer Bone Metastases Model.

F. O'Brien, R. Darcy, C. O’Driscoll, 2017, Molecular pharmaceutics.

Life in 3D is never flat: 3D models to optimise drug delivery.

Kathleen A Fitzgerald, Meenakshi Malhotra, Caroline M Curtin, 2015, Journal of controlled release : official journal of the Controlled Release Society.

The role of transcription factors in prostate cancer and potential for future RNA interference therapy

C. O’Driscoll, Jianfeng Guo, James C. Evans, 2014, Expert opinion on therapeutic targets.

Evidence for the T3-associated 90K heterodimer as the T-cell antigen receptor

E. Reinherz, S. Meuer, O. Acuto, 1983, Nature.

Anisamide-targeted gold nanoparticles for siRNA delivery in prostate cancer - synthesis, physicochemical characterisation and in vitro evaluation.

J. Holmes, C. O’Driscoll, Jianfeng Guo, 2016, Journal of materials chemistry. B.

A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor.

R. Darcy, C. O’Driscoll, M. Malhotra, 2016, International journal of pharmaceutics.

The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics.

Meenakshi Malhotra, Caroline M Curtin, Fergal J O'Brien, 2015, Biomaterials.

Biomimetic gold nanocomplexes for gene knockdown: Will gold deliver dividends for small interfering RNA nanomedicines?

J. Holmes, C. O’Driscoll, Jianfeng Guo, 2015, Nano Research.

Nanoparticle-mediated siRNA delivery assessed in a 3D co-culture model simulating prostate cancer bone metastasis.

Caitriona M O' Driscoll, R. Darcy, R. Raftery, 2016, International journal of pharmaceutics.

The small GTPase Rab4A interacts with the central region of cytoplasmic dynein light intermediate chain-1.

M. Mccaffrey, A. Hendrick, P. Thörnqvist, 2001, Biochemical and biophysical research communications.

The human T cell receptor: appearance in ontogeny and biochemical relationship of alpha and beta subunits on IL-2 dependent clones and T cell tumors.

E. Reinherz, S. Meuer, O. Acuto, 1983, Cell.